Bcr-Abl抑制剂
英文名 | DCC2036 (Rebastinib) | CAS号 | 1020172-07-9 |
试剂别名 |
DCC-2036;2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-, [3aR-[3aa,4a(E),5b,6aa]]-;DCC-2036 (Rebastinib);2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-, [3aR-[...;4-(4-(3-(3-(tert-Butyl)-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpicolinamide;4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;Rebastinib;1-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea;4-[4-({[3-Tert-Butyl-1-(Quinolin-6-Yl)-1h-Pyrazol-5-Yl]carbamoyl}amino)-3-Fluorophenoxy]-N-Methylpyridine-2-Carboxamide;DCC2036;Rebastinib [USAN];N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea;Rebastinib Tosylate;Rebastinib(DCC-2036);4-(4-(3-(3-(tert-Butyl)-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpic;N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(MethylcarbaMoyl)pyridin-4-yl)
|
分子式 | C30H28FN7O3 |
产品编号 | APEB1404 | 分子量 | 553.59 |
MDL号 |
产品名称: | Bcr-Abl抑制剂 |
英文名称: | DCC2036 (Rebastinib) |
英文别名: | DCC-2036;2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-, [3aR-[3aa,4a(E),5b,6aa]]-;DCC-2036 (Rebastinib);2H-Cyclopenta[b]furan-2-one, 5-(benzoyloxy)-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-, [3aR-[...;4-(4-(3-(3-(tert-Butyl)-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpicolinamide;4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide;Rebastinib;1-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)-3-(2-fluoro-4-(2-(methylcarbamoyl)pyridin-4-yloxy)phenyl)urea;4-[4-({[3-Tert-Butyl-1-(Quinolin-6-Yl)-1h-Pyrazol-5-Yl]carbamoyl}amino)-3-Fluorophenoxy]-N-Methylpyridine-2-Carboxamide;DCC2036;Rebastinib [USAN];N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea;Rebastinib Tosylate;Rebastinib(DCC-2036);4-(4-(3-(3-(tert-Butyl)-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpic;N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(MethylcarbaMoyl)pyridin-4-yl) |
中文别名: | DCC-2036 (Rebastinib) 抑制剂;N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲;DCC-2036;DCC-2036 (Rebastinib) 国华试剂 |
CAS No.: | 1020172-07-9 |
分子式: | C30H28FN7O3 |
分子量: | 553.59 |
危险品级别: | |
HS符号: | |
危害声明: |